Potassium Binders
Hyperkalaemia is common in treated HF, especially if on RAAS inhibitor drugs and in the presence of impaired renal function. The signs and/or symptoms of hyperkalaemia include weakness, fatigue, and/or paralysis, nausea and constipation and bradyarrhythmias. ECG changes include peaked T waves, prolo...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Barcaray International
2019-01-01
|
Series: | International Cardiovascular Forum Journal |
Subjects: | |
Online Access: | https://icfjournal.org/index.php/icfj/article/view/621/pdf |